Press releases

Testosterone for nerve fibre repair

To protect against attack, the body uses natural repair processes. What is involved in the spontaneous regeneration of the myelin sheath surrounding nerve fibres? This is the question addressed by researchers in Unit 1195, “Neuroprotective, Neuroregenerative and Remyelinating Small Molecules” (Inserm/Paris-Sud University). They have discovered, in mice, the unexpected regenerative role of testosterone in this process. This could be a factor in the progression of demyelinating diseases, such as multiple sclerosis, which can present differently in women and men, and heralds new therapeutic opportunities.  

These results are published in PNAS.

The myelin sheath allows the rapid transmission of information between the brain or spinal cord and the rest of the body. Myelin may be targeted by conditions known as demyelinating diseases, such as multiple sclerosis or injuries that lead to its destruction. These diseases disrupt neurotransmission, leading to various symptoms including paralysis. Repair mechanisms then come into play, and bring about myelin regeneration and resolution of symptoms. This regenerative process is erratic, for reasons that are still largely unknown. This question was analysed by the research team “Myelination and Myelin Repair” in Unit 1195, “Neuroprotective, Neuroregenerative and Remyelinating Small Molecules.”

In this study, the researchers present evidence of the unexpected central role of the well-known male sex hormone, testosterone, and of its receptor, the androgen receptor, in spontaneous myelin repair.

“Testosterone promotes the production of myelin by the cells that synthesise it in the central nervous system, in order to repair the sheath, which is essential to the transmission of nerve impulses,” explains Elisabeth Traiffort, Inserm Research Director.

In the absence of testes and hence of the hormone, testosterone, that these organs produce, the spontaneous myelin repair process is disrupted in mice. Indeed, the maturation of cells specialised in myelin synthesis, known as oligodendrocytes, is defective. The researchers also showed that control of this maturation, provided by astrocytes, another type of cell with an important role in repair, is what is compromised.

But why testosterone? Returning to the origins of this hormone, it turns out, surprisingly, that the androgen receptor that enables testosterone to act appeared at the same time as myelin, very late in the evolution of gnathostomes (vertebrates with jaws). According to the researchers, this would explain their very strong association in the myelination process.

“It is perhaps also one of the reasons why progression of demyelinating diseases such as multiple sclerosis often differs between men and women. Our results pave the way for new therapeutic opportunities, and might also benefit research on psychiatric diseases or cognitive ageing,” concludes Elisabeth Traiffort, Inserm Research Director.

La sclérose en plaques

Myelin forms a sheath surrounding neurons © Inserm/Carole Fumat

Researcher Contact
Elisabeth Traiffort Directrice de recherche Inserm Unité 1195 Petites Molécules de Neuroprotection, Neurorégénération et Remyélinisation Inserm - Université Paris-Sud +33 (0) 1 49 59 19 02 rf.mresni@troffiart.htebasile Michael Schumacher Directeur de l’Unité 1195 Unité 1195 Petites Molécules de Neuroprotection, Neurorégénération et Remyélinisation Inserm - Université Paris-Sud + 33 (0) 1 49 59 18 95 rf.mresni@rehcamuhcs.leahcim
Press Contact
Juliette Hardy 01 44 23 60 98 rf.mresni@esserp
Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin Bartosz Bielecki a,b, Claudia Mattern c, Abdel M. Ghoumari a, Sumaira Javaid a,d, Kaja Smietanka a,b, Charly Abi Ghanem a, Sakina Mhaouty-Kodja e, M. Said Ghandour f,g, Etienne-Emile Baulieu a,1, Robin J. M. Franklin h,i, Michael Schumacher a,1,2, and Elisabeth Traiffort a,2 a U1195 INSERM and University Paris-Sud and University Paris-Saclay, Kremlin-Bicêtre 94276, France; b Department of Neurology and Stroke, Medical University of Lodz, Lodz, Poland; c Mattern Foundation, Vaduz, Liechtenstein; d Hussain Ebrahim Jamal Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan; e U1130 INSERM, UMR 8246 CNRS, University Pierre and Marie Curie, Paris, France; f UMR 7357 CNRS, University of Strasbourg, Strasbourg, France; g Department of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, VA; h Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; and i Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom 1 To whom correspondence may be addressed. Email: rf.mresni@ueiluab.enneite or rf.mresni@rehcamuhcs.leahcim. 2 M.S. and E.T. contributed equally to this work. PNAS, 08 décembre 2016